We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Bayer Limited

The Atrium, Blackthorn Road, Dublin 18,
Telephone: +353 1 2999 313
Fax: +353 1 2061 456
Patient Information Leaflet last updated on medicines.ie: 08/06/2017
PIL Avelox 400mg Film-coatedTablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 08/06/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Change to section 2 - what you need to know - warnings and precautions
Updated on 30/06/2015 and displayed until 08/06/2017
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Change to improve clarity and readability
  • Addition of information on reporting a side effect.
Updated on 30/05/2014 and displayed until 30/06/2015
Reasons for adding or updating:
  • Addition of information on reporting a side effect.
Updated on 30/07/2012 and displayed until 30/05/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 17/02/2012 and displayed until 30/07/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 22/12/2011 and displayed until 17/02/2012
Reasons for adding or updating:
  • Change to further information section
Updated on 07/10/2011 and displayed until 22/12/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 12/07/2011 and displayed until 07/10/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 25/03/2011 and displayed until 12/07/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 23/03/2011 and displayed until 25/03/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 25/02/2011 and displayed until 23/03/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 16/11/2010 and displayed until 25/02/2011
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to date of revision
Updated on 23/06/2010 and displayed until 16/11/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change to date of revision
  • Change to name of manufacturer
Updated on 18/08/2009 and displayed until 23/06/2010
Reasons for adding or updating:
  • Change to information about driving or using machinery
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 01/02/2008 and displayed until 18/08/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to further information section
  • Change to marketing authorisation holder
  • Addition of marketing authorisation holder
  • Change to date of revision
Updated on 12/12/2006 and displayed until 01/02/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Change to drug interactions
Updated on 01/02/2005 and displayed until 12/12/2006
Reasons for adding or updating:
  • Change to packaging
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 28/07/2004 and displayed until 01/02/2005
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Moxifloxacin hydrochloride